These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20039208)

  • 1. Dopamine agonist induced compulsive eating behaviour in a Parkinson's disease patient.
    Khan W; Rana AQ
    Pharm World Sci; 2010 Apr; 32(2):114-6. PubMed ID: 20039208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding.
    Vitale C; Trojano L; Barone P; Errico D; Agosti V; Sorrentino G; Grossi D; Santangelo G
    Behav Neurol; 2013 Jan; 27(4):559-62. PubMed ID: 23242361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist.
    Salas RE; Allen RP; Earley CJ; Gamaldo CE
    Sleep; 2009 May; 32(5):587-8. PubMed ID: 19480224
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropsychological findings in a case of punding before and after cessation of pramipexole.
    Larson ER
    Clin Neuropsychol; 2015; 29(1):166-78. PubMed ID: 25658417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
    Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compulsive eating and weight gain related to dopamine agonist use.
    Nirenberg MJ; Waters C
    Mov Disord; 2006 Apr; 21(4):524-9. PubMed ID: 16261618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole in psychiatry: a systematic review of the literature.
    Aiken CB
    J Clin Psychiatry; 2007 Aug; 68(8):1230-6. PubMed ID: 17854248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
    Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
    Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequency and range of sexual behavior in a patient with Parkinson's disease after use of pramipexole: a case report.
    Munhoz RP; Fabiani G; Becker N; Teive HAG
    J Sex Med; 2009 Apr; 6(4):1177-1180. PubMed ID: 18466265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.
    Bostwick JM; Hecksel KA; Stevens SR; Bower JH; Ahlskog JE
    Mayo Clin Proc; 2009 Apr; 84(4):310-6. PubMed ID: 19339647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
    Hassan A; Bower JH; Kumar N; Matsumoto JY; Fealey RD; Josephs KA; Ahlskog JE
    Parkinsonism Relat Disord; 2011 May; 17(4):260-4. PubMed ID: 21310646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
    Bienfait KL; Menza M; Mark MH; Dobkin RD
    J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine dysregulation syndrome in Parkinson's disease patients with unsatisfactory switching from immediate to extended release pramipexole: a further clue to incentive sensitization mechanisms?
    Solla P; Cannas A; Corona M; Marrosu MG; Marrosu F
    Behav Neurol; 2013 Jan; 27(4):563-6. PubMed ID: 23242362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
    Bares M; Rektorová I; Krajcovicová L; Rektor I
    J Neurol; 2008 Oct; 255(10):1596; author reply 1597. PubMed ID: 18758889
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
    Utsumi H; Okuma Y; Kano O; Suzuki Y; Iijima M; Tomimitsu H; Hashida H; Kubo S; Suzuki M; Nanri K; Matsumura M; Murakami H; Hattori N;
    Intern Med; 2013; 52(3):325-32. PubMed ID: 23370739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hiccups in Parkinson's disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature.
    Lertxundi U; Marquínez AC; Domingo-Echaburu S; Solinís MÁ; Calvo B; Del Pozo-Rodríguez A; García M; Aguirre C; Isla A
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1159-1164. PubMed ID: 28600702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulse control disorders in Parkinson's disease: a retrospective analysis of 1824 patients in a 12-year period.
    Gunduz A; Çiftçi T; Erbil AC; Senoglu G; Ser MH; Apaydın H
    Neurol Sci; 2024 Jan; 45(1):171-175. PubMed ID: 37581771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.
    Bennett JP; Piercey MF
    J Neurol Sci; 1999 Feb; 163(1):25-31. PubMed ID: 10223406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.